Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus

ClinicalTrials.gov ID: NCT02143973

Public ClinicalTrials.gov record NCT02143973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Extension Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate the overall safety of nalbuphine HCL ER tablets during a treatment period of up to 24 weeks.

Study identification

NCT ID
NCT02143973
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Trevi Therapeutics
Industry
Enrollment
167 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Type not available)
Primary completion
Jan 2016 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
May 21, 2025

2014 – 2016

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Nephrology Associates PC Birmingham Alabama 35211 —
University South Alabama Medical Center Mobile Alabama 36617 —
Arizona Kidney Disease and Hypertension Center Phoenix Arizona 85012 —
U.S. Renal Care Inc. Pine Bluff Arkansas 71603 —
North America Research Institute Azusa California 91702 —
Pegasus Dialysis Center Bakersfield California 93308 —
Central Nephrology Medical Group Bakersfield California 93309 —
Mark Lee MD, Inc Whittier California 90606 —
Nephrology and Hypertension Associates PC Middlebury Connecticut 06762 —
Pines Clinical Research Pembroke Pines Florida 33025 —
Genesis Clinical Research Tampa Florida 33614 —
DaVita Central Orlando Dialysis Winter Park Florida 32789 —
Southwest Georgia Nephrology Clinic PC Albany Georgia 31701 —
Renal Physicians of Georgia Macon Georgia 31217 —
Pacific Renal Research Institute Meridian Idaho 83642 —
Fresenius Medical Care of Evergreen Park Evergreen Park Illinois 60805 —
Western New England Renal and Transplant Association Springfield Massachusetts 01107 —
Nephrology Center DBA Paragon Health Kalamazoo Michigan 49007 —
McComb Limited Care Facility McComb Mississippi 39648 —
Kidney Associates of Kansas City PC Kansas City Missouri 64131 —
Nephrology-Hypertension Associates of Central New Jersey PA North Brunswick New Jersey 80902 —
Renal Medicine Associates Albuquerque New Mexico 87109 —
Newtown Dialysis Center Inc Astoria New York 11102 —
Durham Nephrology Associates Durham North Carolina 27704 —
Wake Nephrology Associates PA Raleigh North Carolina 27609 —
Brookview Hills Research Associates LLC Winston-Salem North Carolina 27103 —
University of Cincinnati Cincinnati Ohio 45267 —
Nephrology Research Consortium Bethlehem Pennsylvania 18017 —
Delaware Valley Nephrology Philadelphia Pennsylvania 19118 —
Dialysis Clinic, Inc. Philadelphia Pennsylvania 19140 —
Carolina Diabetes and Kidney Center Sumter South Carolina 29150 —
SouthEast Renal Research Institute Chattanooga Tennessee 37408 —
U.S. Renal Care, Inc. Fort Worth Texas 76105 —
U.S. Renal Care Inc. Fort Worth Texas 76164 —
U.S. Renal Care Inc Mansfield Texas 76063 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02143973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02143973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →